Drug Profile
AZD 4121
Alternative Names: AZD4121Latest Information Update: 03 Nov 2008
Price :
$50
*
At a glance
- Originator AstraZeneca
- Class Antihyperlipidaemics
- Mechanism of Action Cholesterol absorption inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Lipid metabolism disorders
Most Recent Events
- 31 Jul 2007 Phase-I clinical trials in Lipid metabolism disorders in United Kingdom (unspecified route)